Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Headwinds Against Amazon May Be Rising

The e-commerce giant saw an ominous slowing of revenues in a tough fourth quarter as the company continued to ramp up spending.

Chrysler Sales Skyrocket in January

Chrysler follows up a strong December and 2011 full-year report by announcing a 44% increase in U.S. sales for February.

What’s a Better Buy — Energy Stocks or Partnerships of the Same Name?

Are income-rich MLPs and energy partnerships better plays than oil and gas stocks of the same name?

Amazon Skewered After Hours — Tuesday’s IP Market Recap

And Netflix, RadioShack got beat up during the day.

Symantec Doing Damage Control Over Hack

Either Symantec knew or suspected it had been hacked in 2006 and said nothing or it didn't know until Anonymous announced it. Either way, Symantec loses.

‘Spam’ Linked to Diabetes in Native Americans

A new study raises questions about processed meat intake among Native Americans living on reservations and the development of diabetes.

EMC: Strong Earnings and a Deep Bench

Four talented and qualified executives work under CEO Tucci, making a succession plan a little tougher to figure out than usual. Who is likeliest to move up?

Gold Finishing a Monster Month of Gains

Gold bullion was headed for its biggest monthly gain of the century Tuesday morning, with silver up too. Miners' gains were much more mixed and muted.

CEOs with 20 Most Exorbitant Golden Parachutes in History

CEO pay and executive compensation gets a bad rap, in part due to the massive golden parachutes for execs. Here are the most egregious in history.

Gannett: Still Waiting for the Digital Payoff

Strong online growth still can't offset the steady declines in print. That's the same problem plaguing other newspaper publishers as well.

Amylin Gets a Boost From Its Diabetes Drug Approval

FDA approval of Bydureon -- a once-a-week injectable drug -- could make Amylin a takeover target for a Big Pharma.

Someone Has to Crunch All That Clinical Trial Data

That's where a slew of info-tech companies, ranging from giant Oracle to tiny BioClinica, come in. However, investing is them is no slam dunk.

Greece Back to Biting Markets — Monday’s IP Market Recap

Never far away, Europe's woes grabbed investors' attention on Monday. But at least the losses were mostly trimmed by day's end.

Industrials Report Earnings Surprises

Caterpillar, Nucor, Eaton, and Steel Dynamics beat expectations. And Cat predicts a rise in U.S. construction spending -- which would be the first since 2004.

Value to Shoppers Equals Value for Investors

These retailers are doing well because they offer superior products or discounts on quality products. So consumers are spending -- wisely.

Keystone or Not, the Big Winner Is Canada

Canada is moving quickly to ramp up construction of a pipeline to its West Coast to facilitate exports to energy-hungry China.

The Great Facebook Profitability Question

No one really knows yet how much it it earns -- if anything. Given some of the costs required to run Facebook, profitability shouldn't be assumed.

Gold, Silver Drop as Greek, Euro Debt Worries Flare Again

Gold and silver price declines Monday morning were broadly hitting miners, with Agnico-Eagle the worst off while Hecla and Silver Standard were holding ground.

Chrysler Will Add 1,600 Jobs in Illinois

The hires will help make the new compact Dodge Dart at Chrysler's Belvidere assembly plant, which also produces Jeep Compass and Jeep Patriot models.